Prostate therapy is linked to heart risk

Using androgen deprivation therapy (ADT) to treat prostate cancer could double the risk of death from heart disease, US researchers have claimed.

ADT is used to treat high-risk localised prostate cancer and has proved effective in improving survival rates.

For the study, the researchers collected data on 3,262 patients treated by surgical removal of the prostate and 1,630 patients treated with radiation therapies. Of these patients, 1,015 were also treated with ADT.

Over a four-year follow-up, 131 patients died of heart disease. Among men aged 65-plus who had their prostates removed, the five-year incidence of heart disease related death was 5.5 per cent for those receiving ADT, compared with 2 per cent for those not treated with ADT.

For men younger than 65, the incidence of heart disease was 3.6 per cent for those on ADT and 1.2 per cent among those who did not receive ADT.

An increased risk of death was observed in men who received ADT in addition to radiation, but this relationship was not statistically significant.

The researchers suggest that ADT increases the risk of heart disease by increasing BMI, causing fat deposition and decreasing insulin sensitivity.

These conditions lead to metabolic syndrome, which increases the risk of developing coronary artery disease.

Lead researcher Dr Henry Tsai, from Harvard Medical School in Boston, said: 'The results of this study support the view that ADT may contribute to death from cardiovascular causes.

'It highlights the importance of careful cardiovascular evaluation before initiating ADT in patients with prostate cancer.'

However, he added that the study was limited by a short follow-up time with few cardiovascular events observed.

All risk factors for cardiovascular death could not be controlled because the study was based on retrospective analysis.

sanjay.tanday@haymarket.com

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Proportion of NHS GPs trained in EEA stabilises despite Brexit uncertainty

Proportion of NHS GPs trained in EEA stabilises despite Brexit uncertainty

The proportion of NHS GPs trained in the EEA has stabilised after a steady decline...

GPs split on calls to suspend appraisal for duration of pandemic

GPs split on calls to suspend appraisal for duration of pandemic

Senior GPs are divided over calls for appraisal to be halted for the rest of the...

GP fears rising over covert recording of consultations in pandemic

GP fears rising over covert recording of consultations in pandemic

Fears over patients covertly recording consultations have increased among GPs since...

Coronavirus: Key guidance GPs need to know about COVID-19

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...

Care home vaccination to begin as Scottish minister says Pfizer vaccine packs can be split up

Care home vaccination to begin as Scottish minister says Pfizer vaccine packs can be split up

Vaccination of care home residents against COVID-19 will start on 14 December in...

How will the COVID-19 vaccination programme get underway?

How will the COVID-19 vaccination programme get underway?

Following the MHRA's approval of Pfizer/BioNTech's COVID-19 jab the government has...